Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptorsXiaoliu Zhang, K Sugita, Itaru Kuroda et al.|Leukemia|2012Cited by 17
Diverse underlying proliferation response to growth factors in imatinib-treated Philadelphia chromosome-positive leukemiasAtsushi Nemoto, Kanji Sugita, Takeshi Inukai et al.|Leukemia Research|2012Cited by 1